Surface Bone Tumour | Hands and Feet | High Local Recurrence | Benign but Mimics Malignancy
KEY DISTINCTIONS
Critical Must-Knows
- Nora lesion is a benign surface-based osteocartilaginous proliferation most common in the hands and feet
- No medullary continuity with the host bone (unlike osteochondroma) — the single most discriminating feature
- Cartilage appears bizarre and hypercellular on histology, frequently mistaken for chondrosarcoma — overdiagnosis is a well-known pitfall
- Local recurrence rates of 50-70 percent after marginal excision, but no malignant transformation reported
- Treatment is marginal excision; re-excision for recurrence is curative
Clinical Pearls
- "BPOP = no medullary continuity (unlike osteochondroma)
- "Hands and feet = think Nora lesion before parosteal osteosarcoma
- "Bizarre cartilage does NOT mean malignancy in this context
- "High recurrence is expected; counsel patients preoperatively
Critical Nora Lesion Exam Points
Definition
Bizarre parosteal osteochondromatous proliferation (BPOP). A benign reactive surface lesion of bone that produces a well-circumscribed mass of bone and cartilage attached to the cortex. First described by Nora et al. in 1983.
Site Predilection
Hands and feet predominate. Phalanges (most common), metacarpals, metatarsals, and proximal/middle phalanges. Can occur in long bones but is far less common there.
The Trap
Histologic mimicry of malignancy. Cartilage is hypercellular with enlarged, bizarre chondrocytes. Pathologists unfamiliar with BPOP may call it chondrosarcoma or parosteal osteosarcoma. Clinical-radiologic correlation is essential.
Recurrence
50-70 percent local recurrence after marginal excision. Recurrence is typically within 2 years. Re-excision is curative. No distant metastasis or malignant transformation has been reported.
Quick Decision Guide
| Feature | Nora Lesion (BPOP) | Osteochondroma | Parosteal Osteosarcoma |
|---|---|---|---|
| Medullary continuity | Absent | Present (diagnostic) | Absent |
| Typical location | Hands, feet (phalanges, MC/MT) | Metaphysis of long bones (knee, proximal humerus) | Distal femur posterior (long bones) |
| Age | 2nd-3rd decades (range wide) | Adolescents (growth plate active) | 3rd-4th decades |
| Cartilage histology | Bizarre, hypercellular, but benign | Normal-appearing cartilage cap | Low-grade osteoid production |
NORANora Lesion Key Features
| N | No medullary continuity The mass sits on the cortex without connection to the medullary canal |
| O | Osteocartilaginous surface mass Mature bone with a cartilage cap attached to the cortex |
| R | Recurrence is common 50-70 percent recur after excision, but repeat excision cures |
| A | Acral sites predominate Hands and feet (phalanges, metacarpals, metatarsals) |
| N | No medullary continuity The mass sits on the cortex without connection to the medullary canal | R | Recurrence is common 50-70 percent recur after excision, but repeat excision cures |
| O | Osteocartilaginous surface mass Mature bone with a cartilage cap attached to the cortex | A | Acral sites predominate Hands and feet (phalanges, metacarpals, metatarsals) |
Hook:NORA: No medullary continuity, Osteocartilaginous, Recurs a lot, Acral sites!
CARTDifferentiating BPOP from Osteochondroma
| C | Continuity Osteochondroma has medullary continuity; BPOP does not |
| A | Anatomy location BPOP favours hands/feet; osteochondroma favours long bone metaphyses |
| R | Radiologic border BPOP is well-circumscribed on cortex; osteochondroma flares from bone |
| T | Tumour behaviour Both benign, but BPOP recurs far more frequently after excision |
| C | Continuity Osteochondroma has medullary continuity; BPOP does not | R | Radiologic border BPOP is well-circumscribed on cortex; osteochondroma flares from bone |
| A | Anatomy location BPOP favours hands/feet; osteochondroma favours long bone metaphyses | T | Tumour behaviour Both benign, but BPOP recurs far more frequently after excision |
Hook:CART: Continuity, Anatomy, Radiologic border, Tumour behaviour — the four pillars for BPOP vs osteochondroma!
SAFEAvoiding the Malignancy Trap
| S | Site matters Hands and feet with bizarre cartilage = think BPOP first, not sarcoma |
| A | Age consideration Young patient with surface hand/foot mass favours BPOP over malignancy |
| F | Florid reactive periostitis spectrum BPOP belongs to the florid reactive periostitis family; not a true neoplasm |
| E | Expert path review Always request musculoskeletal pathologist review to avoid misdiagnosis |
| S | Site matters Hands and feet with bizarre cartilage = think BPOP first, not sarcoma | F | Florid reactive periostitis spectrum BPOP belongs to the florid reactive periostitis family; not a true neoplasm |
| A | Age consideration Young patient with surface hand/foot mass favours BPOP over malignancy | E | Expert path review Always request musculoskeletal pathologist review to avoid misdiagnosis |
Hook:SAFE: Site, Age, Florid spectrum, Expert path review — do not overcall malignancy!
Overview and Epidemiology
Why This Matters
Nora lesion is rare but has a striking tendency to be misdiagnosed as chondrosarcoma or parosteal osteosarcoma on histology alone. The bizarre, hypercellular cartilage mimics malignancy, yet the lesion is entirely benign. Understanding this entity prevents catastrophic overtreatment — including unnecessary wide resection or amputation — particularly in the hands and feet where functional preservation is paramount.
Epidemiology
- Age: 2nd and 3rd decades most common, but ranges from childhood to the elderly
- Sex: No strong sex predilection; slight female predominance in some series
- Incidence: Rare; exact incidence unknown, but account for a minority of surface bone lesions
- Sites: Phalanges of hands and feet (most common), followed by metacarpals and metatarsals; long bones less frequently
Clinical Presentation
- Mass: Painless or mildly tender swelling on the surface of a bone in the hand or foot
- Growth: Slowly enlarging over months to years
- Functional impact: May cause mechanical irritation, deformity of adjacent digit, or limit motion
- History: Often no preceding trauma identified, though trauma has been proposed as a trigger
Pathophysiology
Pathogenesis and Classification
Nora lesion (BPOP) is classified as a reactive or pseudoneoplastic proliferation rather than a true neoplasm. It belongs to the spectrum of florid reactive periostitis and bizarre parosteal osteochondromatous proliferation. The exact aetiology is unknown, but proposed mechanisms include reactive changes from trauma or chronic irritation. The lesion produces mature bone and cartilage that grows on the cortical surface. The cartilage cap shows hypercellularity, enlarged chondrocytes, and bizarre nuclei that mimic chondrosarcoma — but there is no evidence of true malignant transformation. Fluorescence in situ hybridisation (FISH) studies have demonstrated rearrangements of collagen genes (COL12A1 and COL1A2), supporting a clonal but benign process.
Florid Reactive Periostitis Spectrum
| Entity | Features | Location | Key Differentiator |
|---|---|---|---|
| Bizarre parosteal osteochondromatous proliferation (BPOP / Nora lesion) | Well-formed bone and cartilage mass on cortex | Phalanges, hands, feet | Most organized; mature bone with cartilage cap |
| Florid reactive periostitis | Fasciitis-like spindle cell proliferation with reactive new bone | Phalanges, hands | Less organized bone; more spindle cell component |
| Subungual exostosis | Mature bone arising from distal phalanx under the nail | Distal phalanx (great toe, thumb) | Specific distal phalangeal location; clinically distinct |
Histopathology
Bone component: Mature, well-formed trabecular bone with a cartilage cap
Cartilage component: Hypercellular with enlarged, bizarre chondrocytes; may show binucleated cells and myxoid change
No cytologic atypia: Despite the bizarre appearance, mitoses are absent and there is no infiltrative growth
No permeation: Unlike chondrosarcoma, there is no infiltration of pre-existing bone trabeculae
Molecular Features
COL12A1 rearrangements: Reported in BPOP by FISH analysis
COL1A2 rearrangements: Also identified, supporting a clonal proliferation
Tumour syndromes: Not associated with HME (EXT1/EXT2) or any hereditary syndrome
Clinical significance: Molecular testing can help differentiate BPOP from osteochondroma and parosteal osteosarcoma in difficult cases
Classification and Types
Radiographic Classification
| Radiographic Feature | Typical Appearance | Significance |
|---|---|---|
| Location | Cortical surface of phalanges, metacarpals, or metatarsals | Acral predilection is the strongest clinical clue |
| Morphology | Well-circumscribed mass of mature bone on the cortex | Well-defined borders suggest benignity |
| Medullary continuity | Absent — no connection between lesion and medullary canal | Key distinguishing feature from osteochondroma |
| Cartilage cap | May be visible as a radiolucent zone at the periphery | Cartilage is typically more prominent than expected for the size |
| Underlying cortex | Intact, may show slight cortical thinning or scalloping | Cortical destruction would raise concern for malignancy |
The radiographic hallmark of Nora lesion is a well-circumscribed, surface-based osteocartilaginous mass on a short tubular bone (hand or foot) with no medullary continuity.
Clinical Assessment
History
- Duration: Slowly growing mass over months to years
- Pain: Usually painless or mildly tender
- Trauma: May or may not recall preceding injury
- Function: May notice progressive deformity or limited range of motion of the digit
Examination
- Inspection: Firm, non-mobile mass on the surface of a phalanx, metacarpal, or metatarsal
- Palpation: Bony hard, fixed to the underlying bone, non-tender or mildly tender
- Overlying skin: Typically normal; no erythema or warmth
- Neurovascular: Intact distally; check for nerve compression if large lesion
Clinical-Radiologic-Pathologic Correlation is Mandatory
The diagnosis of Nora lesion requires correlation of all three domains. Biopsy interpretation without knowledge of the radiologic appearance and clinical setting (young patient, hand/foot location, surface-based lesion) is the primary cause of misdiagnosis as sarcoma. Always ensure the pathologist has access to the imaging and clinical details before a final diagnosis is rendered.
Differential Diagnosis of Surface Bone Lesions
| Condition | Location | Medullary Continuity | Discriminating Feature |
|---|---|---|---|
| Nora lesion (BPOP) | Phalanges, MC/MT (hands and feet) | Absent | Bizarre cartilage, high recurrence, benign behaviour |
| Osteochondroma | Long bone metaphyses (knee, humerus) | Present | Continuous medullary canal; normal cartilage cap |
| Parosteal osteosarcoma | Distal femur posterior (long bones) | Absent | Low-grade osteoid in fibrous stroma; radiologic wrapping/tail sign |
| Periosteal chondroma | Surface of long bones (humerus, femur) | Absent | Purely cartilaginous; no bone formation within the mass |
| Florid reactive periostitis | Phalanges, hands | N/A | More spindle cell component; less organized bone |
| Subungual exostosis | Distal phalanx (great toe, thumb) | Absent | Subungual location; clinically distinct presentation |
Don't Confuse BPOP with Parosteal Osteosarcoma
Parosteal osteosarcoma is the most dangerous mimic. Both are surface-based bone lesions without medullary continuity. Key differentiators: parosteal osteosarcoma occurs in long bones (especially the posterior distal femur), shows a radiologic wrapping or tail sign around the cortex, and contains low-grade osteoid within a fibrous stroma rather than the mature bone and bizarre cartilage of BPOP. Site is the strongest discriminator: a surface lesion on a hand or foot phalanx is far more likely to be BPOP than parosteal osteosarcoma.
Investigations
Imaging Protocol
Views: PA, lateral, and oblique of the affected digit/foot
Look for: Well-circumscribed surface bone mass, intact cortex, absence of medullary continuity, no soft tissue mass or aggressive features
Key sign: A surface-based osteocartilaginous mass on a short tubular bone without medullary connection is highly suggestive of BPOP
Indication: Confirm the absence of medullary continuity and better define the lesion-cortex interface
Findings: Mature bone mass on the cortical surface; no connection to the medullary canal; intact underlying cortex
Pre-op planning: Define the extent of the lesion for surgical excision planning
Indication: If there is concern for soft tissue extension, nerve/vessel involvement, or to differentiate from sarcoma
Findings: Well-defined surface lesion with cartilage cap signal characteristics; no marrow oedema or soft tissue mass
Important: MRI helps exclude the aggressive features expected in parosteal osteosarcoma
Imaging Pearl
The single most important imaging feature to assess is medullary continuity. If the medullary canal of the host bone is continuous with the lesion, it is an osteochondroma, not a Nora lesion. CT is the best modality for confirming this. If medullary continuity is absent and the lesion is on a hand or foot bone, BPOP is the leading diagnosis.
Management Algorithm
Marginal Excision (Primary Treatment)
Goal: Complete excision of the surface mass with a narrow margin of normal tissue while preserving adjacent neurovascular structures and joint function
Surgical Protocol
Imaging review: CT to confirm surface location and plan approach
Biopsy: Consider pre-operative core needle biopsy only if diagnosis is uncertain; if radiologic appearance is classic for BPOP in a characteristic location, excision may proceed without prior biopsy
Consent: Counsel regarding 50-70 percent recurrence risk and possible need for re-excision
Approach: Direct approach over the mass, protecting neurovascular structures
Excision: Marginal excision — remove the mass with a thin cuff of surrounding tissue
Cortex: Smooth the underlying cortex; remove all visible lesion
Closure: Standard soft tissue closure; may need local tissue rearrangement if defect is large
Immobilization: Brief splinting for soft tissue healing (1-2 weeks for digits)
Mobilization: Early range of motion exercises once wound healed
Path review: Ensure musculoskeletal pathologist reviews specimen with clinical-radiologic correlation
Surveillance: Clinical and radiographic review at 3 months, 6 months, 12 months, then annually
Recurrence: Most recurrences occur within 2 years
Re-excision: If recurrence is detected, repeat marginal excision is the treatment
Management Pearl
The key principle is marginal excision with careful follow-up. Wide resection or amputation is never indicated for Nora lesion. The high recurrence rate is expected and managed by re-excision. Over-treating due to misdiagnosis as sarcoma is the greatest iatrogenic harm.
Complications
| Complication | Incidence | Risk Factors | Management |
|---|---|---|---|
| Local recurrence | 50-70 percent | Incomplete excision, location at joint-adjacent site | Repeat marginal excision; curettage of the cortical base |
| Misdiagnosis as sarcoma | Reported in multiple case series | Pathologist unfamiliar with BPOP, inadequate clinical info | Always request expert musculoskeletal pathology review |
| Scar/digital stiffness | Variable, dependent on approach | Multiple excisions, dorsal approach to digit | Hand therapy, early mobilization, splinting |
| Neurovascular injury | Rare | Large lesion, revision surgery, poor anatomy | Careful dissection; loupe magnification for digital surgery |
| Pathological fracture | Rare | Large lesion weakening the cortex | Protect digit during healing; internal fixation rarely needed |
The Greatest Risk is Misdiagnosis, Not the Lesion Itself
The most devastating "complication" of Nora lesion is iatrogenic: unnecessary wide resection or amputation performed because the lesion was misdiagnosed as chondrosarcoma or parosteal osteosarcoma. Multiple case reports in the literature document this scenario. Always ensure clinical-radiologic-pathologic correlation before committing to an aggressive surgical plan for any surface bone lesion in the hands or feet.
Outcomes and Prognosis
Outcomes After Treatment
| Scenario | Treatment | Expected Outcome | Long-term Function |
|---|---|---|---|
| Primary excision (no recurrence) | Marginal excision | Cured; normal function restored | Full digital/hand function preserved |
| One recurrence | Re-excision | Cured in most cases after second procedure | Good function; minor stiffness possible |
| Multiple recurrences | Repeat marginal or en bloc excision | Eventually cured; no malignant transformation | May have cumulative stiffness from repeated surgery |
| Misdiagnosed as sarcoma (overtreated) | Wide resection or amputation | Unnecessary functional loss | Preventable with expert pathology review |
Prognostic Summary
Nora lesion is universally benign. No case of malignant transformation has ever been reported. The main morbidity is local recurrence (50-70 percent), which is managed with re-excision. The main risk is misdiagnosis leading to overtreatment. Prognosis for function is excellent when managed correctly.
Evidence Base and Key Trials
Bizarre parosteal osteochondromatous proliferations of the hands and feet
- Original description of 35 cases of a distinct clinicopathologic entity
- Surface-based osteocartilaginous lesions of the hands and feet with bizarre cartilage
- Recurrence rate of approximately 50-70 percent after excision
- No malignant transformation despite concerning histologic appearance
Bizarre parosteal osteochondromatous proliferation of bone (Nora's lesion)
- 13 cases reviewed with emphasis on histologic features and recurrence patterns
- Cartilage showed marked hypercellularity with bizarre chondrocytes mimicking chondrosarcoma
- All cases were benign; no metastases or malignant transformation
- Emphasized the importance of clinical and radiographic correlation to avoid misdiagnosis
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)
- COL1A1 and COL1A2 mutations identified in BPOP, along with fusions involving noncoding RNA genes
- Molecular findings support a clonal neoplastic process rather than a purely reactive proliferation
- These genetic alterations are distinct from those found in osteochondroma (EXT1/EXT2) and parosteal osteosarcoma
- Molecular testing may serve as an adjunct diagnostic tool in challenging cases
Bizarre parosteal osteochondromatous proliferation (Nora's lesion) in the hand
- Review of BPOP with emphasis on hand presentation and radiologic-pathologic correlation
- CT is the preferred modality to demonstrate absence of medullary continuity
- Multiple recurrences are common but do not indicate malignant change
- Correct diagnosis requires integration of clinical, radiographic, and histologic findings
Exam Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
Scenario 1: Surface Lesion of the Proximal Phalanx
"A 24-year-old woman presents with a slowly enlarging, painless firm mass on the radial aspect of the proximal phalanx of her right middle finger. It has been present for 18 months. Plain radiographs show a well-circumscribed bony mass arising from the cortical surface of the proximal phalanx. There is no connection between the lesion and the medullary canal. The underlying cortex is intact. What is your diagnosis and management?"
Scenario 2: Recurrence After Excision
"A 30-year-old man underwent excision of a surface bone lesion from his third metatarsal 14 months ago. The original pathology report described 'bizarre parosteal osteochondromatous proliferation consistent with Nora lesion.' He now presents with a recurrent mass at the same site. Radiographs show a similar-appearing surface bone mass. The patient is anxious that the lesion may be malignant. How do you manage this?"
Guidelines, Registries & Global Practice
Global Epidemiology
- Rare worldwide: No population-based incidence data; reported across all continents
- No ethnic predilection: Cases reported in diverse populations
- Age distribution: Most common in 2nd and 3rd decades but ranges from adolescents to the elderly
- Acral predilection: The hand and foot predominance is consistent across all reported series globally
Practice Variation by Resource Setting
- High-resource: CT or MRI for characterization, musculoskeletal pathology review, hand/foot surgeon excision
- Limited-resource: Plain radiographs often sufficient for diagnosis; excision by any trained orthopaedic surgeon
- Universal principle: The diagnosis is primarily clinical-radiologic; pathology review confirms but should not be interpreted in isolation
- Key message: In any resource setting, avoid misdiagnosis as sarcoma by correlating clinical, radiographic, and histologic findings
Society and Reference Guidance (Side by Side)
| Source | Diagnostic Emphasis | Treatment | Key Message |
|---|---|---|---|
| WHO Classification of Bone Tumours | Intermediate/benign surface lesion; bizarre cartilage is characteristic | Marginal excision; re-excision for recurrence | BPOP is a recognized entity; do not confuse with osteochondroma or parosteal osteosarcoma |
| NCCN / Musculoskeletal tumour guidelines | Clinical-radiologic-pathologic correlation essential; biopsy if uncertain | Marginal excision by tumour-trained surgeon | Surface lesions of hands/feet warrant specialist path review |
| BOA / BSSH / Orthopaedic oncology centres | CT to confirm no medullary continuity; MRI if sarcoma concern | Marginal excision; MDT discussion if diagnosis uncertain | Do not overtreat; BPOP recurs but never metastasizes |
| Textbook consensus (Unni, Fletcher, WHO) | Histology mimics chondrosarcoma; clinical context essential | Excision with narrow margins; never wide resection | Misdiagnosis is the greatest risk — educate pathologists |
Evidence Note
The evidence for BPOP is derived entirely from case series, case reports, and review articles. There are no randomized trials and no prospectively validated diagnostic criteria. The diagnosis rests on the combination of characteristic acral location, absence of medullary continuity on imaging, and typical (though alarming-appearing) histology with benign clinical behaviour.
Global Learning Point (Globally Applicable)
Every orthopaedic surgeon and pathologist should know Nora lesion because:
- It is the most commonly overdiagnosed as sarcoma among surface bone lesions
- Unnecessary amputations and wide resections have been reported due to this misdiagnosis
- The single most discriminating feature is no medullary continuity on CT
- A surface bone mass on a hand or foot in a young patient with no medullary continuity should prompt consideration of BPOP before sarcoma
Controversies & Areas of Uncertainty
Reactive vs neoplastic
BPOP has historically been considered a reactive process, but molecular studies showing clonal gene rearrangements (COL12A1, COL1A2) suggest it may be a benign neoplasm. The distinction has no practical impact on management but is of academic interest.
Role of pre-operative biopsy
Some authors recommend biopsy before excision if there is diagnostic uncertainty; others argue that classic radiologic features are sufficient to proceed directly to excision. No consensus exists, and practice varies by institution and surgeon experience.
Optimal surgical margin
Marginal excision is universally recommended, but the extent of cortical curettage or smoothing at the base is variable. Some surgeons advocate more aggressive local treatment of the cortical bed to reduce recurrence, but evidence is anecdotal.
Long-term surveillance duration
Most recurrences occur within 2 years, but late recurrences have been reported. There is no consensus on the optimal duration of follow-up. Most authors recommend clinical and radiographic review for at least 2-3 years post-operatively.
NORA LESION (BPOP)
Clinical summary
Definition & Key Features
- •Benign surface osteocartilaginous proliferation of hands and feet
- •No medullary continuity with host bone (vs osteochondroma)
- •Bizarre hypercellular cartilage on histology mimics chondrosarcoma
- •First described by Nora et al. in 1983
Diagnosis
- •Clinical: young patient, painless surface mass on a digit/hand/foot bone
- •Radiologic: well-circumscribed surface mass, no medullary continuity on CT
- •Pathologic: mature bone with bizarre cartilage cap, no mitoses or permeation
- •Mandatory clinical-radiologic-pathologic correlation
Differential Diagnosis
- •Osteochondroma: has medullary continuity (the key difference)
- •Parosteal osteosarcoma: long bones, tail/wrapping sign, low-grade osteoid
- •Periosteal chondroma: purely cartilaginous, no bone in the mass
- •Florid reactive periostitis: more spindle cell, less organized bone
Treatment & Recurrence
- •Marginal excision is the definitive treatment — never wide resection
- •50-70 percent local recurrence rate, typically within 2 years
- •Re-excision for recurrence is curative in most cases
- •No malignant transformation has ever been reported
Critical Exam Pitfalls
- •Do not misdiagnose as chondrosarcoma based on histology alone
- •Do not perform wide resection or amputation for BPOP
- •Always check for medullary continuity — present = osteochondroma, absent = BPOP
- •Hands and feet + surface mass + young patient = think BPOP first